1. “Borisovskiy Zavod Medicinskikh Preparatov” JSC “Borisovskiy Zavod Medicinskikh Preparatov” JSC

2. Brief view Pharmaceutical factory Joint Stock Company “Borisovskiy Zavod Medicinskikh Preparatov” is the leading manufacture and the exporter of broad-spectrum drugs in the Republic of Belarus. The factory was established in 1965. The company town of “Borisovskiy Zavod Medicinskikh Preparatov” JSC is above 11 hectares. Total employment at the factory is 2700 persons. Production volume in the actual prices for 2013 – 917.3 billion rubles (103.3 million USD) Now JCS “Borisovskiy Zavod Medicinskikh Preparatov” is a modern dynamically developing pharmaceutical factory with new technology and high quality production and skilled personal. slide 1 “Borisovskiy Zavod Medicinskikh Preparatov” JSC

3. Brief view JSC “ BZMP” holds participating shares in the companies: slide 2 “Borisovskiy Zavod Medicinskikh Preparatov” JSC Belarus- German JV Fresenius-Borisov- Dialysetechnik (JV “FREBOR” OOO) Participating shares of JSC “BZMP” – 78.2% OOO “Borisov KZ” (Kazakhstan) Participating shares of JSC “BZMP”– 30% BORIMED LTD (Kyrgyzstan) Participating shares of JSC “BZMP”– 50% OOO “Boripharm” (RF) Participating shares of JSC “BZMP”– 100% “Borisovskiy Zavod Medicinskikh Preparatov” JSC

4. slide 3 “Borisovskiy Zavod Medicinskikh Preparatov” JSC

5. Brief view The core business of “Borisovskiy Zavod Medicinskikh Preparatov” JSC Ampoule production and powder for injections in vials (antibiotics) tablet production production of liquid photochemical and soft medical drugs production of hard capsule drugs slide 4 “Borisovskiy Zavod Medicinskikh Preparatov” JSC

6. Production volume in the actual prices in 2012- 747,8 billions rubles, in 2013 – 917,3 billion rubles (103,3 million USD). Production volume in comparable prices Billions rubles / growth rate to the previous year Billons rubles Short summary slide 5 “Borisovskiy Zavod Medicinskikh Preparatov” JSC

7. slide 6 “Borisovskiy Zavod Medicinskikh Preparatov” JSC Production pattern for 2013

8. Export pattern Republic of Belarus Russian Federation Kazakhstan Uzbekistan Tajikistan Turkmenistan Kyrgyzstan Ukraine Moldova Armenia Latvia Lithuania Estonia Azerbaijan Georgia Afghanistan USA Iraq Somalia Yemen Lebanon Macedonia Production was exported to 24 regions including CIS countries, Russia, nearby and foreign countries. Vietnam DPRK EGYPT slide 7 “Borisovskiy Zavod Medicinskikh Preparatov” JSC

9. Portion of JSC “BZMP” in total domestic production of medical drugs for 2013 (million packs) BZMP JSC keeps 36% of sales of medical drugs sold by domestic in the Republic of Belarus (on the basis of quantities). slide 8 “Borisovskiy Zavod Medicinskikh Preparatov” JSC 1 2 3 4 5 6 7 8 9 1 2 3 4 5 6 7 8 9

10. slide 9 “Borisovskiy Zavod Medicinskikh Preparatov” JSC Portion of BZMP JSC in total sales of medical drugs in the Republic of Belarus for 2013 (million packs) BZMP JSC keeps 26% for sales of medical drugs in the Republic of Belarus (on the basis of quantities) 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

11. Export pattern Export ratio (%) in total volume exports for 2013, thousand USD In 2013 export of production amounted to 55.4 million USD. slide 10 “Borisovskiy Zavod Medicinskikh Preparatov” JSC

12. slide 11 “Borisovskiy Zavod Medicinskikh Preparatov” JSC Volume of export In 2013 export volume amounts to 55.4 million US dollars or 105.6 % of the corresponding period last year.

13. TOP - 10 of medical drugs Rating placeName Sales volume for 2013 (local sales + export) In thousand USD 1 Valeriane extract, coated tablets 20 mg, №50 4527 2 Acetylsalicylic acid, tablets 500 mg №10 3639 3 Ceftriaxone, powder for injections, 1 g 3436 4Analgin 50% №10 2553 5Citramon-Borimed, tablets №6 2488 6 Sodium chloride, 0,9% solution for injections, 5ml №10 1859 7Cefazolin, powder for injections, 1 g 1833 8 Folic acid, tablets №50 1655 9Lidocaine, solution for injections 2 ml 1590 10Cyanocobalamin, solution for injections 1502 slide 12 “Borisovskiy Zavod Medicinskikh Preparatov” JSC

14. DEALERS NET “Borisovskiy Zavod Medicinskikh Preparatov”JSC № п/п Country Number of dealers 1 Kazakhstan 23 2 Russian Federation 10 3 Uzbekistan 10 4 Moldova 11 5 Georgia 7 6 Azerbaijan 7 7 Other foreign countries 14 8 Turkmenistan 4 9 Kyrgyzstan 3 10 Tajikistan 5 11 Ukraine 2 12 Armenia 2 Total 9898 Structure of dealer net slide 13 “Borisovskiy Zavod Medicinskikh Preparatov” JSC

15. New medical drugs Name of drugPharmacologic 2009 Zovasticor, tabl.Hypolipemic (lowers the level of cholesterol in the blood) Chloropiramin, sol. for ing.Antihistamine preparation, inhibitor of H1- histamine receptors Lidocaine, sol. for ing.For solution of cephalosporin antibiotics of III generation Spasmatone, sol. for ing., tablAnalgesics and antispasmodics, non-narcotic Ketozoral, tabl.Anti-fungous Roxitromicyn – Borimed, tabl.Antibiotic macrolide 2010 Borinem, sol. for ing.Antibiotic carbopenem Aspicard, tabl.Non-steroidal anti-inflammatory drugs – acetilsalicylic acid Lansazole, caps.Inhibitor of proton pump BoriVit, sol. for ing.Hypoglycemic means, decreases sugar in blood Klindacil, sol. for ing.Antibiotic lincosamides group 2011 Lizinopril-Borimed,tabl.Inhibitor ACE (arterial hypertension, chronicle heart dysfunction) Ribavirin-Borimed, caps. Intivirus preparation Metformin-Borimed, tabl.For hypoglycemia treatment, per oral use, group Biguanid Risperidon-Borimed, tabl.Antipsychotic Sulpirid, caps.Antipsychotic Sedative dropsCombined sedative preparation “Borisovskiy Zavod Medicinskikh Preparatov” JSC

16. New medical drugs New medical drugs New medical drugs Name of drug Pharmacologic 2012 Metromizol-Dent, gel combined antimicrobial agent for dentistry use Gliclazide, tabl.2 nd generation sulfonylurea antidiabetic agent Clindacyl, caps.lincosamide antibiotic Clarithromycin, tabl.macrolide antibiotic Bisoprolol, tabl.hypotensive, antiarrythmic and antianginal remedy Ondansetron, tabl.antiemetic agent Ethambutol, tabl.antituberculous remedy Choline Alfascerate, sol. for inj. nootropic agent slide 15 “Borisovskiy Zavod Medicinskikh Preparatov” JSC

17. “Borisovskiy Zavod Medicinskikh Preparatov” JSC New medical drugs New medical drugs New medical drugs Name of drug Pharmacologic 2013 Valerianae Forte, tabl.sedative and soporific Wite tablet, tabl.enterosorbent additional source of dietary fiber ProctoMaz ointment agent for the treatment of hemorrhoids Meloxicam, tabl.non-steroidal anti-inflammatory drug Magnekard,tabl.platelet aggregation inhibitors slide 16

18. Sales volume pattern in the Republic of Belarus for 2013 Increase of sales for 2013(compared to 2012) : Total increase of sales for 2013 – 130,7% (compared to 2012) Amounts to 435.6 billion rubles ( 49.0 mln. USD) slide 17 “Borisovskiy Zavod Medicinskikh Preparatov” JSC

19. Implementation of international standards All main production sectors have GMP certificate and monitored in accordance with the quality standards of GMP. The factory was certified with: Quality and Operational Health and Safety Management Quality Management Systems for medical drugs and biologically active additives conformity STB ISO 9001 -2009. Environment Management Systems for production and sales of medical drugs (ecological certificate) STB ISO 14001:2005 Occupational Health & Safety System Certification for production and sale of medical drug and biologically active additives - STB 18001-2009 Certificate of Conformity for Production of Valeriane extract tablets accordingly to the EC standards issued by Latvian Certification Centre. slide 18 “Borisovskiy Zavod Medicinskikh Preparatov” JSC

20. “Borisovskiy Zavod Medicinskikh Preparatov” JSC Award of the government of the Republic of Belarus Award of government of the Republic of Belarus in the field quality 2011 is awarded to open joint stock company ‘Borisovskiy Zavod Medicinskikh Preparatov”. The company is awarded for its high efficient quality management and assurance of production of quality competitive products. slide 19

21. Proposal on cooperation slide 20 “Borisovskiy Zavod Medicinskikh Preparatov” JSC We offer to create a joint venture on the basis of existing sites of JSC “BZMP”: 1. Joint venture for production of solutions for injections in ampoules Collective investment fund – 45.5 mln USD Participant’s quotas: JSC “BZMP” – 25.5 mln USD – 56.0% Investor – 20.0 mln USD – 44.0% JSC “BZMP”: a)hands over its existing production sites and equipment for production of solutions for injections in ampoules; b)hands over the whole range of products in the form of solutions for injections. Investor: a)pays the cost of the reconstruction of ampoule production; b)offers a new range of medical products.

22. “Borisovskiy Zavod Medicinskikh Preparatov” JSC Proposal on cooperation 2. Joint venture for production of medical products in the form of tablets Collective investment fund – 23.2 mln USD Participant’s quotas: JSC “BZMP” – 8.2 mln USD – 35.4% Investor – 15.0 mln USD – 64.6% JSC “BZMP”: a)hands over a part of its existing production sites and equipment for production of medical products in the form of tablets; b)hands over a part of the range of products in the form of tablets. Investor: a)pays the cost of the reconstruction of existing tablet production; b)offers a new range of medical products. We invite you for cooperation! slide 21

23. Health, the dearest value is trusted to us ! slide 22 “Borisovskiy Zavod Medicinskikh Preparatov” JSC